A phase 1 dose-escalation study on the safety, tolerability and activity of liposomal curcumin (Lipocurc™) in patients with locally advanced or metastatic cancer.

Greil, R, Greil-Ressler, S, Weiss, L, Schönlieb, C, Magnes, T, Radl, B, Bolger, GT, Vcelar, B, Sordillo, PP.

/https://www.ncbi.nlm.nih.gov/pubmed/30074076